These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2427300)
41. Leads from the MMWR. Isolation of HTLV-III/LAV from samples of serum proteins given to cancer patients--Bahamas. JAMA; 1985 Sep; 254(9):1139. PubMed ID: 2991620 [No Abstract] [Full Text] [Related]
42. Intravenous drug abuse and the accident and emergency department: AIDS (HTLV-III) antibodies and hepatitis B markers. Dunlop MG; Steedman DJ; Peutherer JF Arch Emerg Med; 1986 Dec; 3(4):257-9. PubMed ID: 3026414 [No Abstract] [Full Text] [Related]
43. LAV/HTLV-III antibodies in connective tissue diseases. Gioud-Paquet M; Kahn MF; Rouzioux C; Brun-Vezinet F; Rey MA Lancet; 1985 Sep; 2(8454):554. PubMed ID: 2863569 [No Abstract] [Full Text] [Related]
44. Reactivity of Bushman sera with HTLV-III--what does it mean? de St J van der Riet F; Hesseling PB S Afr Med J; 1985 Apr; 67(16):617-8. PubMed ID: 2984796 [No Abstract] [Full Text] [Related]
46. [Absence of anti-LAV antibodies in connective tissue diseases]. Gioud Paquet M; Kahn MF; Rouzioux C; Brun-Vezinet F; Rey MA Presse Med; 1986 Apr; 15(17):802. PubMed ID: 3012506 [No Abstract] [Full Text] [Related]
47. High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol. Fuchs D; Blecha HG; Deinhardt F; Dierich MP; Goebel FD; Hengster P; Hinterhuber H; Schoenitzer D; Traill K; Wachter H Lancet; 1985 Jun; 1(8444):1506. PubMed ID: 2861431 [No Abstract] [Full Text] [Related]
48. HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Rodgers-Johnson P; Gajdusek DC; Morgan OS; Zaninovic V; Sarin PS; Graham DS Lancet; 1985 Nov; 2(8466):1247-8. PubMed ID: 2866324 [No Abstract] [Full Text] [Related]
49. HTLV-III antibodies in a remote population of eastern Zaire. Gray RH; Wawer MJ Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1662. PubMed ID: 2988689 [No Abstract] [Full Text] [Related]
50. Transmission of HTLV-II. Chorba T JAMA; 1986 Dec; 256(22):3094. PubMed ID: 2878093 [No Abstract] [Full Text] [Related]
51. HTLV-III antibodies in drug addicts in Spain. Rodrigo JM; Serra MA; Aguilar E; del Olmo JA; Gimeno V; Aparisi L Lancet; 1985 Jul; 2(8447):156-7. PubMed ID: 2862347 [No Abstract] [Full Text] [Related]
52. Lack of seroconversion to human T-cell lymphotropic virus, type III, after intravenous immune globulin. Bussel JB Transfusion; 1986; 26(4):399. PubMed ID: 3014693 [No Abstract] [Full Text] [Related]
53. Absence of antibodies to HTLV-III on Bougainville (Papua New Guinea). Hrdy DB; Carlson JR; Friedlaender JS Med J Aust; 1986 Jun; 144(13):723. PubMed ID: 3014284 [No Abstract] [Full Text] [Related]
54. HTLV-III antibodies after hepatitis B vaccination. Kessler H; Chase R; Harris A; Jensen D; Levin S Lancet; 1985 Jun; 1(8444):1506-7. PubMed ID: 2861432 [No Abstract] [Full Text] [Related]
57. Regional variations in HIV antibody seropositivity in British intravenous drug users. Robertson JR; Bucknall AB; Wiggins P Lancet; 1986 Jun; 1(8495):1435-6. PubMed ID: 2872528 [No Abstract] [Full Text] [Related]
58. Isolation of Non-modified gamma globulin for intravenous use. Schneider W; Wolter D; McCarty LJ Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(6):938-45. PubMed ID: 64437 [TBL] [Abstract][Full Text] [Related]
59. HIV antibodies in commercial immune globulins. Piszkiewicz D; Mankarious S; Holst S; Dillon K Lancet; 1986 Jun; 1(8493):1327. PubMed ID: 2872451 [No Abstract] [Full Text] [Related]